Episode Synopsis "Episode 180: The VALOR-HCM Trial"

Milind Desai and C. Michael Gibson compare the results of mavacamten for severe obstructive hypertropic cardiomyopathy with the typical treatments of surgical septal myectomy or alcohol ablation.

Listen "Episode 180: The VALOR-HCM Trial"

More episodes of the podcast Talking Points

• The AXIOMATIC - SSP Trial
• The EBRAVE - AF Trial
• The INVICTUS Trial
• The FRAME-AMI Trial
• MASTER DAPT: Long-Term Results
• Episode 180: The PANTHER Trial
• Radial vs. Femoral Access for PCI: Meta-Analysis
• Episode 181: ACT Outpatient and Inpatient Trials
• Episode 180: The VALOR-HCM Trial
• Episode 179: The SODIUM-HF Study
• Episode 178: The COMPLETE Trial
• Episode 177: The EDIT-CMD Trial
• Episode 176: The IVVE Trial
• Episode 175: The METEORIC-HF Trial
• Episode 174: The DIAMOND Trial
• Episode 173: MAVA-LTE: The EXPLORER-LTE Cohort